The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
2020 · Scientific Reports · 107 citations
https://doi.org/10.1038/s41598-020-66458-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
1.2K
Citations
12
h-index
12
i10-index
Rebecca Caffrey is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Diet, Metabolism, and Disease & Advanced Proteomics Techniques and Applications. The author has an h-index of 12, co-authored 22 publications.
Click to start Chat